NL8101531A - Stabiele, geconcentreerde oplossing van cisplatine; werkwijze voor de bereiding daarvan; farmaceutische samenstellingen. - Google Patents
Stabiele, geconcentreerde oplossing van cisplatine; werkwijze voor de bereiding daarvan; farmaceutische samenstellingen. Download PDFInfo
- Publication number
- NL8101531A NL8101531A NL8101531A NL8101531A NL8101531A NL 8101531 A NL8101531 A NL 8101531A NL 8101531 A NL8101531 A NL 8101531A NL 8101531 A NL8101531 A NL 8101531A NL 8101531 A NL8101531 A NL 8101531A
- Authority
- NL
- Netherlands
- Prior art keywords
- cisplatin
- solution
- polyethylene glycol
- stable
- molecular weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13537380A | 1980-03-31 | 1980-03-31 | |
US13537380 | 1980-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL8101531A true NL8101531A (nl) | 1981-10-16 |
Family
ID=22467813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8101531A NL8101531A (nl) | 1980-03-31 | 1981-03-27 | Stabiele, geconcentreerde oplossing van cisplatine; werkwijze voor de bereiding daarvan; farmaceutische samenstellingen. |
Country Status (30)
Country | Link |
---|---|
JP (1) | JPS56152415A (es) |
KR (1) | KR860000841B1 (es) |
AR (1) | AR225500A1 (es) |
AT (1) | AT370996B (es) |
AU (1) | AU541056B2 (es) |
BE (1) | BE888209A (es) |
CA (1) | CA1162479A (es) |
CH (1) | CH647481A5 (es) |
CS (1) | CS246051B2 (es) |
DD (1) | DD157762A5 (es) |
DE (1) | DE3112272A1 (es) |
DK (1) | DK158564C (es) |
ES (1) | ES500869A0 (es) |
FI (1) | FI70670C (es) |
FR (1) | FR2480605A1 (es) |
GB (1) | GB2074028B (es) |
GR (1) | GR72769B (es) |
HU (1) | HU183379B (es) |
IE (1) | IE51070B1 (es) |
IL (1) | IL62517A (es) |
IT (1) | IT1170838B (es) |
LU (1) | LU83270A1 (es) |
NL (1) | NL8101531A (es) |
NO (1) | NO156675C (es) |
NZ (1) | NZ196519A (es) |
PH (1) | PH17152A (es) |
PT (1) | PT72774B (es) |
SE (1) | SE455045B (es) |
SU (1) | SU1056893A3 (es) |
ZA (1) | ZA812084B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1153974B (it) * | 1982-09-23 | 1987-01-21 | Erba Farmitalia | Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento |
NL8303657A (nl) * | 1983-10-24 | 1985-05-17 | Pharmachemie Bv | Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan. |
FI895340A0 (fi) * | 1988-11-14 | 1989-11-09 | Bristol Myers Squibb Co | Hypertonisk cisplatin-loesning. |
JP2001501173A (ja) * | 1996-08-23 | 2001-01-30 | アルザ コーポレイション | シスプラチン化合物を含有するリポソーム |
AUPQ641100A0 (en) | 2000-03-23 | 2000-04-15 | Australia Nuclear Science & Technology Organisation | Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents |
JP4445304B2 (ja) | 2004-03-26 | 2010-04-07 | オンキヨー株式会社 | スイッチングアンプ |
US8852566B2 (en) * | 2009-03-26 | 2014-10-07 | Warsaw Orthopedic, Inc. | Compositions and methods for preferential distribution of active agents to injury sites |
US11752135B2 (en) | 2018-03-29 | 2023-09-12 | Project Pharmaceutics Gmbh | Liquid pharmaceutical formulation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4177263A (en) * | 1972-02-28 | 1979-12-04 | Research Corporation | Anti-animal tumor method |
SE445172B (sv) * | 1978-05-30 | 1986-06-09 | Bristol Myers Co | Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform |
-
1981
- 1981-03-06 AU AU68166/81A patent/AU541056B2/en not_active Ceased
- 1981-03-06 CA CA000372499A patent/CA1162479A/en not_active Expired
- 1981-03-17 NZ NZ196519A patent/NZ196519A/xx unknown
- 1981-03-24 FR FR8105848A patent/FR2480605A1/fr active Granted
- 1981-03-24 IT IT48090/81A patent/IT1170838B/it active
- 1981-03-25 CH CH2023/81A patent/CH647481A5/fr not_active IP Right Cessation
- 1981-03-26 FI FI810934A patent/FI70670C/fi not_active IP Right Cessation
- 1981-03-26 GR GR64497A patent/GR72769B/el unknown
- 1981-03-27 NL NL8101531A patent/NL8101531A/nl not_active Application Discontinuation
- 1981-03-27 SE SE8101990A patent/SE455045B/sv not_active IP Right Cessation
- 1981-03-27 PH PH25435A patent/PH17152A/en unknown
- 1981-03-27 ZA ZA00812084A patent/ZA812084B/xx unknown
- 1981-03-27 DE DE19813112272 patent/DE3112272A1/de active Granted
- 1981-03-28 KR KR1019810001029A patent/KR860000841B1/ko active
- 1981-03-30 IE IE715/81A patent/IE51070B1/en not_active IP Right Cessation
- 1981-03-30 NO NO811081A patent/NO156675C/no unknown
- 1981-03-30 DK DK144281A patent/DK158564C/da not_active IP Right Cessation
- 1981-03-30 SU SU813265697A patent/SU1056893A3/ru active
- 1981-03-30 HU HU81811A patent/HU183379B/hu not_active IP Right Cessation
- 1981-03-30 PT PT72774A patent/PT72774B/pt not_active IP Right Cessation
- 1981-03-30 AR AR284799A patent/AR225500A1/es active
- 1981-03-30 JP JP4569081A patent/JPS56152415A/ja active Granted
- 1981-03-30 IL IL62517A patent/IL62517A/xx unknown
- 1981-03-30 GB GB8109926A patent/GB2074028B/en not_active Expired
- 1981-03-30 ES ES500869A patent/ES500869A0/es active Granted
- 1981-03-31 CS CS812390A patent/CS246051B2/cs unknown
- 1981-03-31 LU LU83270A patent/LU83270A1/fr unknown
- 1981-03-31 DD DD81228776A patent/DD157762A5/de not_active IP Right Cessation
- 1981-03-31 AT AT0150481A patent/AT370996B/de not_active IP Right Cessation
- 1981-03-31 BE BE0/204323A patent/BE888209A/fr not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4451447A (en) | Pharmaceutical formulations | |
KR100351713B1 (ko) | 백금(ii) 항종양제의 안정용액 | |
US4670262A (en) | Novel pharmacological compositions based on Cisplatinum and method for obtaining same | |
US5023335A (en) | 1,2-bis (aminomethyl) cyclobutane-platinum complexes | |
SE450830B (sv) | Stabil mikrokristallin cis-platina(ii)-diamin-diklorid och forfarande for dess framstellning | |
NL8101531A (nl) | Stabiele, geconcentreerde oplossing van cisplatine; werkwijze voor de bereiding daarvan; farmaceutische samenstellingen. | |
FI116058B (fi) | Kolme ydintä käsittävät kationiset platinakompleksit, joilla on kasvaimenvastainen vaikutus, sekä niitä sisältävät farmaseuttiset koostumukset | |
US4544759A (en) | Platinum complexes of antitumor agents | |
SE445172B (sv) | Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform | |
SK17742000A3 (sk) | Komplex platiny s oxidačným číslom ii, spôsob prípravy tohto komplexu, tento komplex ako liečivo a farmaceutická kompozícia obsahujúca tento komplex | |
JPS62289591A (ja) | テトラヒドロ−3,4−フランジアミン−n,n’−白金錯体 | |
EP0397147A2 (en) | Stable solutions of rebeccamycin analog and preparation thereof | |
Mann et al. | β β'β"-Triaminotriethylamine and its complex metallic compounds | |
US4946689A (en) | Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin | |
JPS60215631A (ja) | インタ−ロイキン−2組成物 | |
KR900004404B1 (ko) | 유기백금착물 및 이를 사용한 종양 치료방법 | |
FI72302C (fi) | Foerfarande foer framstaellning av stabilt mikrokristallint cisplatin. | |
KR20040060958A (ko) | 인터페론-γ 생산 촉진제 | |
WO2019220961A1 (ja) | ダリナパルシンのアルカリ金属塩及び/又は無機酸付加塩の結晶型及びその製剤 | |
EP0639978B1 (en) | Pharmaceutical combination having antineoplastic activity | |
Keppeler et al. | Syntheses and Antiviral Activities of Some 5′‐O‐Acyl Derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BT | A notification was added to the application dossier and made available to the public | ||
A85 | Still pending on 85-01-01 | ||
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
DNT | Communications of changes of names of applicants whose applications have been laid open to public inspection |
Free format text: BRISTOL-MYERS SQUIBB COMPANY |
|
BV | The patent application has lapsed |